McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

ChatRWD™ Beta from Atropos Health Exceeds Big Tech LLMs on Physician Trust and Ability to Answer Questions Completely with High-Quality Evidence in New Study

by McKesson Ventures | Jul 2, 2024 | Press Releases

On July 2, real-world data healthcare technology company Atropos Health announced in a press release the publication of its new research paper, “Answering Real-World Clinical Questions Using Large Language Model Based Systems.” The paper offers a detailed look into...

Atropos Health Raises $33M To Scale The Automation Of High-Quality, Personalized Real-World Evidence Leveraging Generative AI

by McKesson Ventures | May 23, 2024 | Portfolio News, Press Releases

On Thursday, May 23, real-world data healthcare technology company Atropos Health announced that it had secured a $33 million Series B financing round, in light of the recent adoption of the company’s GENEVA OS™ platform, which is now being used by a variety of...

SSM Health partners with Inbound Health to offer in-home advanced care to patients

by McKesson Ventures | Apr 24, 2024 | Portfolio News, Press Releases

Inbound Health and SSM Health have partnered up to offer post-hospital in-home health care services to patients. The SSM Health at Home program – Recovery Care at Home – will apply to certain patients who are ready to be discharged but who still need services...

CancerIQ CEO Feyi Ayodele Named to Modern Healthcare’s 2024 Innovators List

by McKesson Ventures | Apr 9, 2024 | Press Releases

On April 9, 2024, CancerIQ’s Founder and CEO Feyi Ayodele was named as one of Modern Healthcare’s Top Innovators of 2024. The list acknowledges innovators that are improving quality and access to care, as well as constantly striving to improve the clinical and...

Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicators Used for Checkpoint Inhibitor Therapy

by McKesson Ventures | Apr 8, 2024 | Press Releases

On Monday, April 8, 2024, Florida-based biotechnology research company Aster Insights announced that it has partnered with the Food & Drug Administration (FDA) to examine the relationship between the scoring algorithms used in diagnostic testing and key patient...

Saama Redefines the Future of Clinical Development with Groundbreaking GenAI and Collaborative Platform Enhancements

by McKesson Ventures | Jan 22, 2024 | Press Releases

On Monday, January 22nd, life science solutions company Saama announced a variety of new additions to its AI-based platform. The new features include the release of generative AI chat, interactive review listings, and an increased prioritization of cross-functional...
Page 5 of 42« First«...34567...102030...»Last »

Recent Posts

  • Latent Raises $80M to Close the Gap Between Diagnosis and Treatment
  • Midi Health Surpasses $1B Valuation, Igniting a New Era for Women’s Health
  • Oath Surgical Announces AI-Native Surgical Centers Powered by NVIDIA
  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
  • Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings